Alerts will be sent to your verified email
Verify EmailTHEMISMED
Themis Medicare
|
Ind-Swift Lab.
|
Unichem Lab
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
R&D as a % of Total Sales
|
2.68 % | 3.87 % | 0.94 % |
Financials
|
|||
5 yr Average ROE
|
13.04 % | 1.54 % | -1.8 % |
5yr average Equity Multiplier
|
1.72 | 2.88 | 1.25 |
5yr Average Asset Turnover Ratio
|
0.67 | 0.52 | 0.39 |
5yr Avg Net Profit Margin
|
11.29 % | 0.9 % | -3.43 % |
Price to Book
|
5.47 | 1.01 | 1.73 |
P/E
|
43.96 | 16.67 | 286.49 |
5yr Avg Cash Conversion Cycle
|
62.75 Days | 169.25 Days | 134.58 Days |
Inventory Days
|
82.4 Days | 144.46 Days | 136.89 Days |
Days Receivable
|
126.49 Days | 144.51 Days | 147.31 Days |
Days Payable
|
162.52 Days | 91.2 Days | 232.31 Days |
5yr Average Interest Coverage Ratio
|
5.22 | 1.32 | -1.13 |
5yr Avg ROCE
|
16.01 % | 8.03 % | -1.02 % |
5yr Avg Operating Profit Margin
|
18.66 % | 22.42 % | 5.06 % |
5 yr average Debt to Equity
|
0.4 | 1.6 | 0.09 |
5yr CAGR Net Profit
|
n/a | 10.46 % | 53.41 % |
5yr Average Return on Assets
|
8.13 % | 0.55 % | -1.39 % |
Shareholdings
|
|||
Promoter Holding
|
67.15 % | 42.0 % | 70.22 % |
Share Pledged by Promoters
|
2.43 % | 48.57 % | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-0.11 % | 0.0 | 19.29 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 1.59 % |
Themis Medicare
|
Ind-Swift Lab.
|
Unichem Lab
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Verticals
|
Verticals
|
-
|
-
|